Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001383387 | SCV001582519 | pathogenic | Congenital myasthenic syndrome 5 | 2022-10-05 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs759874172, gnomAD 0.003%). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1071042). This premature translational stop signal has been observed in individuals with congenital myasthenic syndrome (PMID: 22678886, 28024842). This sequence change creates a premature translational stop signal (p.Gly126Alafs*38) in the COLQ gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COLQ are known to be pathogenic (PMID: 22678886). |
Baylor Genetics | RCV001383387 | SCV004214459 | pathogenic | Congenital myasthenic syndrome 5 | 2023-06-13 | criteria provided, single submitter | clinical testing |